EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting Cancer Stem Cells as the Key Driver of Carcinogenesis and Therapeutic Resistance

Refaat A Eid iD, Muhammad Alaa Edeen iD, Eslam M Shedid, Al Shaimaa S Kamal, Mona M Warda, Farag Mamdouh iD, Sohila A Khedr, Mohamed A Soltan iD, Hee Won Jeon, Mohamed Samir A Zaki iD, Bonglee Kim iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24021786 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Refaat A Eid und 10 weiteren Autor:innen. Beteiligte Einrichtung: Pathology Department, College of Medicine, King Khalid University, Abha P.O. Box 62529, Saudi Arabia. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Neoplasms. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 186 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Khalid University, National Research Foundation of Korea, Korea government (MSIT).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emerging concept of cancer stem cells (CSCs) as the key driver behind carcinogenesis, progression, and diversity has displaced the prior model of a tumor composed of cells with similar subsequently acquired mutations and an equivalent capacity for renewal, invasion, and metastasis. This significant change has shifted the research focus toward targeting CSCs to eradicate cancer. CSCs may be characterized using cell surface markers. They are defined by their capacity to self-renew and differentiate, resist conventional therapies, and generate new tumors following repeated transplantation in xenografted mice. CSCs’ functional capabilities are governed by various intracellular and extracellular variables such as pluripotency-related transcription factors, internal signaling pathways, and external stimuli. Numerous natural compounds and synthetic chemicals have been investigated for their ability to disrupt these regulatory components and inhibit stemness and terminal differentiation in CSCs, hence achieving clinical implications. However, no cancer treatment focuses on the biological consequences of these drugs on CSCs, and their functions have been established. This article provides a biomedical discussion of cancer at the time along with an overview of CSCs and their origin, features, characterization, isolation techniques, signaling pathways, and novel targeted therapeutic approaches. Additionally, we highlighted the factors endorsed as controlling or helping to promote stemness in CSCs. Our objective was to encourage future studies on these prospective treatments to develop a framework for their application as single or combined therapeutics to eradicate various forms of cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmNeoplasmsAnimalsMiceCarcinogenesisSignal TransductionNeoplastic Stem Cells

Stichwörter der Autor:innen

cancercancer stem cellscarcinogenesisresistancetherapeutic

Autor:innen und Institutionen

  • Pathology Department, College of Medicine, King Khalid University, Abha P.O. Box 62529, Saudi Arabia.
  • Cell Biology, Histology & Genetics Division, Biology Department, Faculty of Science, Zagazig University, Zagazig 44519, Egypt.
  • Biotechnology Division, Zoology Department, Faculty of Science, Benha University, Al Qalyubia Governorate, Banha 13511, Egypt.
  • Biotechnology Department, Faculty of Agriculture, Benha University, Al Qalyubia Governorate, Banha 13511, Egypt.
  • Industrial Biotechnology Department, Faculty of Science, Tanta University, Tanta 31733, Egypt.
  • Department of Microbiology and Immunology, Faculty of Pharmacy, Sinai University, Ismailia 41611, Egypt.

ORCID-Profile: Refaat A Eid, Muhammad Alaa Edeen, Farag Mamdouh, Mohamed A Soltan, Mohamed Samir A Zaki, Bonglee Kim

Förderung

  • King Khalid University
  • National Research Foundation of Korea
  • Korea government (MSIT)
  • Korea Health Industry Development Institute
  • Deanship of Scientific Research of King Khalid University in Abha, Saudi Arabia
  • Ministry of Education
  • Korean government (MSIT)
  • Ministry of Health & Welfare, Republic of Korea

Zitieren

APA

Eid, R. A., Alaa Edeen, M., Shedid, E. M., Kamal, A. S. S., Warda, M. M., Mamdouh, F., Khedr, S. A., Soltan, M. A., Jeon, H. W., Zaki, M. S. A., & Kim, B. (2023). Targeting Cancer Stem Cells as the Key Driver of Carcinogenesis and Therapeutic Resistance. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24021786

Vancouver

Eid RA, Alaa Edeen M, Shedid EM, Kamal ASS, Warda MM, Mamdouh F, et al. Targeting Cancer Stem Cells as the Key Driver of Carcinogenesis and Therapeutic Resistance. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24021786

BibTeX
@article{Eid2023,
  author = {Eid, Refaat A and Alaa Edeen, Muhammad and Shedid, Eslam M and Kamal, Al Shaimaa S and Warda, Mona M and Mamdouh, Farag and Khedr, Sohila A and Soltan, Mohamed A and Jeon, Hee Won and Zaki, Mohamed Samir A and Kim, Bonglee},
  title = {Targeting Cancer Stem Cells as the Key Driver of Carcinogenesis and Therapeutic Resistance},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24021786}
}
Kostenlos starten →